In one such experiment, 30×106 Donor 1 GDTc were injected iv on days 6 and 12 post-leukemia cell injection, along with 100 IU recombinant human IL-2/mouse, plus one additional IL-2 dose on day 21 (Fig. 5b). Here, IL2 is linked to leukemia.